Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant R Goodman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Haematology|April 3, 2003
Cladribine in the treatment of hairy-cell leukaemiaGrant R Goodman, Ernest Beutler, Alan Saven
Current Opinion in Hematology|June 12, 2003
Hairy cell leukemia: an updateGrant R Goodman, Kelly J Bethel, Alan Saven
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Extended follow-up of patients with hairy cell leukemia after treatment with cladribineGrant R Goodman, Carol Burian, James A Koziol, et al.
Drug Safety|October 31, 2022
Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four StudiesGiulio Barteselli, Grant R Goodman, Yogesh Patel, et al.
Clinical Pharmacology in Drug Development|July 1, 2020
Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady-State Pharmacokinetics of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation-Positive MalignanciesWeijiang Zhang, Michael Mathisen, Grant R Goodman, et al.
The Lancet. Oncology|February 26, 2018
Adjuvant vemurafenib in resected, BRAF<sup>V600</sup> mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Karl Lewis, Lev Demidov, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2019
Health-related quality of life in patients with fully resected BRAF<sup>V600</sup> mutation-positive melanoma receiving adjuvant vemurafenibDirk Schadendorf, Anna Maria Di Giacomo, Lev Demidov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2015
Multiple Gastrointestinal Polyps in Patients Treated with BRAF InhibitorsRavi K Amaravadi, Kathryn E Hamilton, Xiaohong Ma, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Haematology|April 3, 2003
Cladribine in the treatment of hairy-cell leukaemiaGrant R Goodman, Ernest Beutler, Alan Saven
Current Opinion in Hematology|June 12, 2003
Hairy cell leukemia: an updateGrant R Goodman, Kelly J Bethel, Alan Saven
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Extended follow-up of patients with hairy cell leukemia after treatment with cladribineGrant R Goodman, Carol Burian, James A Koziol, et al.
Drug Safety|October 31, 2022
Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four StudiesGiulio Barteselli, Grant R Goodman, Yogesh Patel, et al.
Clinical Pharmacology in Drug Development|July 1, 2020
Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady-State Pharmacokinetics of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation-Positive MalignanciesWeijiang Zhang, Michael Mathisen, Grant R Goodman, et al.
The Lancet. Oncology|February 26, 2018
Adjuvant vemurafenib in resected, BRAF<sup>V600</sup> mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Karl Lewis, Lev Demidov, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2019
Health-related quality of life in patients with fully resected BRAF<sup>V600</sup> mutation-positive melanoma receiving adjuvant vemurafenibDirk Schadendorf, Anna Maria Di Giacomo, Lev Demidov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2015
Multiple Gastrointestinal Polyps in Patients Treated with BRAF InhibitorsRavi K Amaravadi, Kathryn E Hamilton, Xiaohong Ma, et al.
Pageof 1